Gamow Labs Uses AI Agents to Reanalyze Rare Disease Genomes

Gamow Labs CEO Daniel McKinnon explained on the AI:AM podcast how his company uses AI agents to repeatedly reanalyze undiagnosed rare-disease genomes, previously catching cases missed by prenatal testing.

2026-10-06 ~ 2026-10-07 · 2 related posts

• AI:AM podcast: Gamow Labs uses AI agents to investigate rare genetic diseases — danielmckinn0n · 2026-10-06
• Gamow Labs CEO uses AI to reanalyze rare-disease genomes, found what prenatal sequencing missed — danielmckinn0n · 2026-10-07